期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Rapamycin in fibrotic diseases: beneficial or detrimental agent? 被引量:2
1
作者 XU Xue-feng DAI Hua-ping 《Chinese Medical Journal》 SCIE CAS CSCD 2013年第7期1364-1369,共6页
apamvcin was first isolated from a strain of Sreptomyces hygroscopicus in the early 1970s froma soil sample taken on Easter Island. Because the antiproliferative effects of rapamycin on yeast cell, as well as B and T ... apamvcin was first isolated from a strain of Sreptomyces hygroscopicus in the early 1970s froma soil sample taken on Easter Island. Because the antiproliferative effects of rapamycin on yeast cell, as well as B and T lymphocytes, it was first identified as an antimicrobial agent with potent immunosuppressive activity and has been used in antirejection therapy. 展开更多
关键词 fibrotic disease RAPAMYCIN mammalian target of rapaymycin negative feedback loop antifibrogenesis
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部